Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : KBP-COVID-19
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase I/ Phase II
Recipient : Kentucky BioProcessing
Deal Size : Inapplicable
Deal Type : Inapplicable
BAT Progresses COVID-19 Candidate Vaccine Into Phase I Human Clinical Trials
Details : The COVID-19 vaccine candidate (KBP-COVID-19) will become one of a number of potential vaccines to have progressed beyond pre-clinical testing. Vaccines manufactured using BAT's vaccine platform have the potential to be stable at room temperature.
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
December 16, 2020
Lead Product(s) : KBP-COVID-19
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase I/ Phase II
Recipient : Kentucky BioProcessing
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
